Author Archives: samweiss
With $100,000 in funding from UnitedHealthcare and support from Robert Wood Johnson Foundation Clinical Scholars, and many other community partners and stake holders, the Farm at Penny Lane will be unveiling a new mobile food unit!
With $100,000 in funding from UnitedHealthcare and support from Robert Wood Johnson Foundation Clinical Scholars, and many other community partners and stake holders, the Farm at Penny Lane will be unveiling a new mobile food unit! The mobile food unit will increase nutritious foods to North Carolinians impacted by housing insecurity, homelessness and chronic health conditions in rural … Read more
Effect of tACS on prefrontal neural activity is menstrual phase dependent in patients with premenstrual dysphoric disorder
A case series providing evidence that the impact of tACS is dependent on context of affective and brain state.
Mental Activity as the Bridge Between Neural Biomarkers and Symptoms of Psychiatric Illness
We propose that the best chance to discover biomarkers and treatment targets for psychiatric illness is to investigate the relationship between a specific symptom, the correlated mental activity, and the correlated neural activity signature.
Reward-Based Decision-Making Engages Distinct Modes of Cross-Frequency Coupling
Goal directed behavior and reward evaluation were found to be linked with distinct neural oscillations. Furthermore, mood symptoms of depression appear to be related to reward-evaluation and motivation symptoms appear to be related to goal-directed behavior.
Closed-loop control of bistable symptom states
Response to paper suggesting the precise mechanism for depressive symptom reduction in closed-loop deep brain stimulation could be illuminated by a dynamical systems approach.
Alpha transcranial alternating current stimulation reduces depressive symptoms in people with schizophrenia and auditory hallucinations: a double-blind, randomized pilot clinical trial.
A pilot trials investigating the effect of tACS in treating auditory hallucinations in people with schizophrenia.
A phase II single-arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, acceptability, and preliminary effects
This is one of the first studies to examine the use of a medication to minimize cognitive changes that may occur during chemotherapy for breast cancer.